Understanding the Significance of TIL Therapy for Metastatic Melanoma

Dr. Sylvia Lee, medical oncologist at Seattle Cancer Care Alliance, discusses a Phase II trial underway focusing on TIL therapy or tumor infiltrating lymphocytes for metastatic melanoma patients. Dr. Lee helps us understand what the therapy is, how it works, and why patients with advanced disease should be excited about it. She also discusses the successes seen in clinical trials so far and the hope for continued expansion of research at other cancer centers.
Produced in association with Seattle Cancer Care Alliance

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower